Company Valuation: Rapid Dose Therapeutics Corp.

Data adjusted to current consolidation scope
Fiscal Period: February 2021 2022 2023 2024 2025 2026
Market Cap 1 16.94 26.45 9.322 20.62 22.02 20.28
Change - 56.16% -64.76% 121.17% 6.81% -7.92%
Enterprise Value (EV) 1 19.02 27.85 11.42 22.91 24.61 25.59
Change - 46.42% -59.01% 100.66% 7.42% 3.97%
P/E -7.11x -3.01x -2.44x -4.27x -3.92x -5.88x
PBR -10.7x 105x -3.49x -6.53x -4.23x -2.83x
PEG - -0x 0x -0.4x -0.68x 0.1x
Capitalization / Revenue 64.5x 15.1x 13x 20.2x 10.6x 7.31x
EV / Revenue 72.4x 15.9x 15.9x 22.5x 11.8x 9.23x
EV / EBITDA -10.9x -7.28x -3.56x -8.34x -6.22x -12.8x
EV / EBIT -8.94x -6.47x -3.22x -7.44x -5.9x -11.8x
EV / FCF -21.3x -17.9x 20.7x -12.2x -409x -653x
FCF Yield -4.7% -5.57% 4.83% -8.22% -0.24% -0.15%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0295 -0.0847 -0.0368 -0.041 -0.0434 -0.0255
Distribution rate - - - - - -
Net sales 1 0.2628 1.752 0.7183 1.02 2.085 2.773
EBITDA 1 -1.74 -3.825 -3.205 -2.746 -3.955 -2
EBIT 1 -2.127 -4.302 -3.544 -3.077 -4.172 -2.171
Net income 1 -2.298 -8.487 -3.81 -4.306 -5.404 -3.39
Net Debt 1 2.083 1.398 2.096 2.293 2.589 5.31
Reference price 2 0.2100 0.2550 0.0900 0.1750 0.1700 0.1500
Nbr of stocks (in thousands) 80,667 103,742 103,574 117,810 129,535 135,182
Announcement Date 8/24/21 1/27/23 6/28/23 6/29/24 6/28/25 6/29/26
1CAD in Million2CAD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-33.55x4.42x-453.26x - 97.54M
3.24x0.9x1.34x - 82.32M
-6.46x - - - 75.82M
Average -12.26x 2.66x -225.96x 85.23M
Weighted average by Cap. -13.67x 2.81x -245.19x

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. DOSE Stock
  4. RDTCF Stock
  5. Valuation Rapid Dose Therapeutics Corp.